Follicular lymphoma trials in Iceland

1 trial · From EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1 randomization to tafasitamab for low-risk disease: a phase II study – NLG-FL7

  Where

  Reykjavik

  Age

  18 years and over

  People

  270 worldwide

  Run by

  Karolinska University Hospital

  See details and how to join2023-508196-36-00 · EU 2023-508196-36-00